Loading clinical trials...
Loading clinical trials...
The Application of Subconjunctival Injection of Bevacizumab (Avastin) in the Treatment of Corneal Neovasculization
Conditions
Interventions
subconjunctival injection of bevacizumab ( 1.25 to 2.50 mg)
Locations
1
Taiwan
Department of Ophthalmology, National Taiwan University Hospital,
Taipei, Taipei, Taiwan
Start Date
August 1, 2007
Primary Completion Date
February 1, 2008
Completion Date
February 1, 2008
Last Updated
May 21, 2008
Lead Sponsor
National Taiwan University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions